Patent · US Active

Mammalian cells expressing cytomegalovirus antigens

US10414802B2 · kind B2 · utility

1Cited by

1References

18Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Andrea Carfi · Cambridge, US
Claudio CIFERRI · Oakland, US
Irmgard Maria Rita Hofmann · Wien, AT
Holger Laux · Irslingen, DE
Anders Lilja · Wien, AT
Yingxia Wen · Acton, US

Key dates

Filing date	Oct 29, 2015
Grant date	Sep 17, 2019
Priority date	—
Expiry date	Oct 29, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/16151
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to cytomegalovirus (CMV) proteins suitable for vaccine uses. Provided herein are mammalian host cells, in particular CHO cells, in which the sequence(s) encoding CMV proteins gH, gL, pUL128, pUL130, pUL131 (or a complex-forming fragment thereof) are stably integrated into the genome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.